MicroRNA-709通过影响线粒体功能介导急性肾小管损伤
该研究探讨microRNA-709(miR-709)在急性肾损伤(AKI)中通过损害线粒体功能介导肾小管细胞死亡的致病作用。在顺铂诱导的AKI小鼠模型和人AKI肾组织活检样本中,miR-709在近端小管细胞(PTCs)中显著上调,且其表达与肾损伤严重程度相关。机制上,miR-709靶向抑制线粒体转录因子A(TFAM),导致线粒体功能障碍和细胞凋亡;抑制miR-709可减轻顺铂诱导的肾损伤和线粒体功能障碍。
要点
- miR-709在AKI近端小管细胞中显著上调,且与肾损伤严重程度相关。
- miR-709通过负调控TFAM导致线粒体功能障碍和细胞凋亡。
- 拮抗miR-709可减轻顺铂诱导的小鼠肾损伤和线粒体功能障碍。
核心结论
- miR-709通过负调控TFAM及后续线粒体功能障碍在顺铂诱导的AKI中起重要致病作用。
- miR-709在急性肾小管损伤中具有致病角色,并提示其可作为AKI治疗的潜在新靶点。
研究设计与样本
- 研究采用顺铂诱导的AKI小鼠模型和人AKI肾组织活检样本,并在培养的小鼠近端小管细胞中进行体外实验。
主要发现
- 在顺铂诱导的AKI小鼠模型和人AKI肾组织活检样本中,miR-709在近端小管细胞中显著上调。
- 人AKI患者肾近端小管细胞中miR-709表达与肾损伤严重程度相关。
- 在培养的小鼠近端小管细胞中,过表达miR-709显著诱导线粒体功能障碍和细胞凋亡,而抑制miR-709可改善顺铂诱导的线粒体功能障碍和细胞损伤。
- TFAM是miR-709的靶基因,恢复TFAM可减轻顺铂或miR-709过表达诱导的线粒体功能障碍和细胞损伤。
- 用miR-709 antagomir拮抗miR-709可显著减轻小鼠顺铂诱导的肾损伤和线粒体功能障碍。
临床怎么用
- miR-709可能作为AKI的潜在治疗靶点,但尚需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mitochondrial dysfunction has important roles in the pathogenesis of AKI, yet therapeutic approaches to improve mitochondrial function remain limited. In this study, we investigated the pathogenic role of microRNA-709 (miR-709) in mediating mitochondrial impairment and tubular cell death in AKI. In a cisplatin-induced AKI mouse model and in biopsy samples of human AKI kidney tissue, miR-709 was significantly upregulated in the proximal tubular cells (PTCs). The expression of miR-709 in the renal PTCs of patients with AKI correlated with the severity of kidney injury. In cultured mouse PTCs, overexpression of miR-709 markedly induced mitochondrial dysfunction and cell apoptosis, and inhibition of miR-709 ameliorated cisplatin-induced mitochondrial dysfunction and cell injury. Further analyses showed that mitochondrial transcriptional factor A (TFAM) is a target gene of miR-709, and genetic restoration of TFAM attenuated mitochondrial dysfunction and cell injury induced by cisplatin or miR-709 overexpression in vitro Moreover, antagonizing miR-709 with an miR-709 antagomir dramatically attenuated cisplatin-induced kidney injury and mitochondrial dysfunction in mice. Collectively, our results suggest that miR-709 has an important role in mediating cisplatin-induced AKI via negative regulation of TFAM and subsequent mitochondrial dysfunction. These findings reveal a pathogenic role of miR-709 in acute tubular injury and suggest a novel target for the treatment of AKI.
引用
- Guo Y, Ni J, Chen S, et al. MicroRNA-709 Mediates Acute Tubular Injury through Effects on Mitochondrial Function. J Am Soc Nephrol. 2017. PMID: 29042455. doi:10.1681/ASN.2017040381
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。